throbber
Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`The asserted claims of the ‘739 patent are anticipated or obvious over United States Patent No. 5,855,601 (“Bessler”) in view of U.S.
`Patent Publication No. 2001/0044633 (“Klint”) and U.S. Patent No. 5,332,402 (“Teitelbaum”), alone or in combination with the
`knowledge of a person of ordinary skill in the art ("POSITA") and/or in combination with one or more other references disclosed in
`Medtronic's Invalidity Contentions, including other charted references.
`
`Bessler was filed on June 21, 1996, published on January 5, 1999, so it is prior art under 35 U.S.C. § 102(a), (b) and (e).
`
`The citations provided below are exemplary and do not necessarily include each and every disclosure of the limitation in the reference.
`Medtronic has endeavored to cite to the most relevant portions of the identified prior art, but other portions may additionally disclose,
`either expressly or inherently, and/or render obvious one or more limitations of the asserted claims. Thus, Medtronic reserves the
`right to rely on: (1) uncited portions of the identified prior art; (2) other prior art not identified herein; (3) references that show the
`state of the art (irrespective of whether such references themselves qualify as prior art to the asserted patents); (4) factual testimony
`from the inventors or authors of the prior art references, or purveyors of prior art devices; and/or (5) expert testimony, to provide
`context to or aid in understanding the prior art and the state of the art at the time of the alleged invention.
`
`The lack of a citation for an element should not be deemed an admission that the element is not disclosed or is not inherent in the
`reference. When the chart indicates a particular reference discloses or embodies a limitation, the terms “discloses,” “disclosed,”
`“embodies,” and “embodied” refer to explicit and/or inherent disclosure and/or obvious variations of the actual disclosure. Further, to
`the extent Medtronic asserts that a claim is indefinite, Medtronic has used its best efforts to reasonably interpret the claims to fulfill
`their duties in charting the prior art references.
`
`Where Medtronic cites to a particular drawing or figure in the accompanying charts, the citation encompasses the description of the
`drawing or figure, as well as any text associated with the drawing or figure. Similarly, where citations are made to particular text
`concerning a drawing or figure, the citation encompasses that drawing or figure. Certain identified prior art inherently discloses
`features of the asserted claims. Medtronic reserves the right to rely on inherency to demonstrate the invalidity of the asserted claims.
`Moreover, certain prior art references may inherently disclose certain features of the asserted claims as construed by Colibri.
`Medtronic may rely on cited or uncited portions of the prior art, other documents, factual testimony, and expert testimony to establish
`the inherency of certain features of the prior art to invalidate the asserted claims.
`
`To the extent Colibri contends that the prior art reference does not disclose any particular limitation of the asserted claims of this
`patent, either expressly or inherently, it would have been obvious to a person of ordinary skill in the art as of the date of the alleged
`invention to modify the reference and/or to combine its teachings with other prior art references, including but not limited to the prior
`art references identified in Medtronic’s invalidity contentions and the relevant sections of the claim charts for those references, in a
`manner that renders such claims invalid as obvious.
`
`
`EAST\177349076.1
`
`1
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 1 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`It would have been obvious under 35 U.S.C. § 103 to a person having ordinary skill in the art at the time of the alleged
`invention to combine the teachings of Bessler with the following references:
`
`
`1.
`
`2.
`
`Klint, which was filed on January 28, 2000, published on July 8, 2003, so it is prior art under 35 U.S.C. § 102(a), (b) and
`(e).
`Teitelbaum, which was filed on May 12, 1992, published on July 26, 1994, so it is prior art under 35 U.S.C. § 102(a), (b)
`and (e).
`
`Claim language
`
`1.pre An assembly to treat a native
`heart valve in a patient, the
`assembly for use in
`combination with a
`guidewire, the assembly
`comprising:
`
`Exemplary disclosure
`To the extent this preamble is limiting, Bessler and Leonhardt disclose “[a]n assembly to
`treat a native heart valve in a patient, the assembly for use in combination with a guidewire,
`the assembly comprising.”
`
`For example, Bessler discloses an assembly (an “artificial heart valve”) to treat a native
`valve in a patient:
`
`
`The present invention relates to novel artificial heart valves. More particularly,
`the present invention relates to novel heart valves that are especially adapted
`for placement using minimally invasive surgical techniques and to the method
`and device useful for such placement.
`
`Bessler at col. 1, lines 7-11. Bessler further discloses that the artificial valve is used in
`combination with a guidewire:
`
`
`A guidewire 94 having a blunt end 95 is disposed through a lumen 97 of the
`pusher member 93 and is used to guide the distal end of the catheter 91 to the
`desired site.
`
`Bessler at col. 7, lines 35-38.
`
`Bessler discloses “a prosthetic heart valve including: a stent member having an inner
`channel, the stent member collapsible, expandable and configured for transluminal
`percutaneous delivery, wherein.”
`
`
`2
`
`1.a
`
`a prosthetic heart valve
`including: a stent member
`having an inner channel, the
`stent member collapsible,
`
`
`EAST\177349076.1
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 2 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`expandable and configured
`for transluminal percutaneous
`delivery, wherein
`
`For example, Bessler discloses an artificial heart valve with a stent member that is self-
`expandable:
`
`The invention includes a new heart valve which may be implanted
`percutaneously and transluminally, which heart valve comprises a stent
`member and a valve means. The stent member is self-expanding and has within
`it valve means that permit flow in only one direction.
`
`Bessler at col. 2, lines 57-62. Bessler further discloses that the replacement heart valve
`device is configured for percutaneous delivery.
`
`
`The present invention includes methods and devices for implanting a heart
`valve percutaneously and transluminally. The artificial heart valves of the
`invention, which are capable of exhibiting a variable diameter between a
`compressed or collapsed position and an expanded position, comprise (1) a
`relatively rigid stent member and (2) a flexible valve means. The stent member
`is self-expanding and has a first cylindrical shape in its compressed or
`collapsed configuration and a second, larger cylindrical shape in its expanded
`configuration.
`
`Bessler at col. 3, lines 46-55. The drawings below show the stent in an expanded and
`collapsed configuration:
`
`
`
`EAST\177349076.1
`
`3
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 3 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`
`Bessler at FIG. 4 (showing stent in an expanded configuration).
`
`
`
`
`
`Bessler at FIG. 5 (showing stent in a collapsed configuration).
`
`
`1.b
`
`the stent member includes a
`tubular structure away from a
`central portion that flares at
`
`
`The combination of Bessler and Teitelbaum discloses “the stent member includes a tubular
`structure away from a central portion that flares at both ends in a trumpet-like configuration;
`and”
`
`
`EAST\177349076.1
`
`4
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 4 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`both ends in a trumpet-like
`configuration; and
`
`
`For example, Teitelbaum teaches a tubular structure away from a central portion that flares
`at both ends in a trumpet-like configuration:
`
`
`The percutaneous cardiac valve has two possible designs, each of which
`consists of two components. In the first design, one of the components is a
`meshwork of nitinol wire of approximately 0.008 inch gauge formed into a
`tubular structure with a minimum central diameter of 20 min. Away from its
`central portion, the tubular structure flares markedly at both ends in a trumpet-
`like configuration. The maximum longitudinal dimension of this component
`which shall be referred to as the stent or doubly-flared stent is approximately
`20 mm. The maximum diameter of the flared ends of the stent is approximately
`30 mm. The purpose of the stent is to maintain a semi-rigid patent channel
`through the diseased cardiac valve following its balloon dilation. The flared
`ends of the stent maintain the position of this component across the native
`valve following deployment. The stent contains a thin hydrophilic plastic
`coating that helps prevent thrombus formation along the inner surface of the
`stent.
`
`Teitelbaum at col. 2, lines 21-39.
`
`
`
`EAST\177349076.1
`
`5
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 5 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`
`
`Teitelbaum at FIG. 2.
`
`
`Both Bessler and Teitelbaum recognize the desirability of “anchor[ing] the expanded stent
`member at a desired site” Bessler at col. 2, lines 62-63). Bessler teaches the optional use of
`barbs to aid in achieving this goal (id.). Teitelbaum explains that the purpose of the flared
`stent is to “maintain the position of this component across the native valve following
`deployment” Teitelbaum at col. 2, lines 34-36 and col. 5, lines 63-65. Thus, a POSITA
`would have been motivated to modify Bessler’s device by using a flared stent as taught by
`Teitelbaum in conjunction with, or as an alternative to, Bessler’s optional barbs in order to
`better anchor the device in place and improve sealing, reducing leakage of blood around the
`valve device (known as “paravalvular leakage”).
`
`Bessler discloses “a valve means including two to four individual leaflets made of fixed
`pericardial tissue, wherein the valve means resides entirely within the inner channel of the
`
`6
`
`1.c
`
`a valve means including two
`to four individual leaflets
`
`
`EAST\177349076.1
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 6 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`made of fixed pericardial
`tissue, wherein the valve
`means resides entirely within
`the inner channel of the stent
`member, and wherein no
`reinforcing members reside
`within the inner channel of
`the stent member
`
`stent member, and wherein no reinforcing members reside within the inner channel of the
`stent member.”
`
`For example, Bessler’s valve includes two to four individual leaflets made of fixed
`pericardial tissue:
`
`
`The invention can perhaps be better appreciated by reference to the drawings.
`An artificial heart valve according to the present invention is set forth in FIGS.
`1 to 3. The artificial heart valve 20 is comprised of a stent member 21 and a
`flexible valve means 22. In this embodiment the stent member 21 is comprised
`of stainless steel wire in a sine wave-like configuration as shown in FIG. 1.
`The center portion 23 of valve member 22 is generally arcuate in shape and
`comprises three leaflets 24 as shown, although it is understood that there could
`be from 2 to 4 leaflets. A cuff portion 25 extends from the periphery of the
`circular portion 27 along the outside of the stent member 21 and is attached to
`the stent member 21 by a plurality of sutures 26.
`
`Bessler at col. 5, lines 15-27. To the extent that Bessler does not disclose that the porcine
`pericardium is fixed, it would have been obvious to a POSITA to fix the porcine
`pericardium valve with, for example, glutaraldehyde to improve antigenicity as such was
`well-known in the art. The use of glutaraldehyde for fixing was well-known in the art as
`recognized in Bessler at 6:19-23 and in other prior art including U.S. Pat. No. 5713950
`(“Cox”) at 4:42-45 and 6:26-32 and U.S. Pat. No. 4218782 (Rygg) at 2:1-12.
`
`
`
`
`EAST\177349076.1
`
`7
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 7 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`Bessler at FIG. 2
`
`
`
`
`
`
`Bessler at FIG. 3
`
`
`Bessler further discloses that valve resides entirely within an inner channel of the stent
`member:
`
`
`EAST\177349076.1
`
`8
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 8 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`The flexible valve means is disposed within the cylindrical stent member with
`the arcuate portion transverse of and at some acute angle relative to the stent
`walls.
`
`Bessler at col. 3, lines 57-60.
`
`To the extent that Patent Owner argues that Bessler’s “cuff portion” is part of the valve
`means, Bessler discloses a cuff portion that can be, but is not required to be, on the outside
`of the stent.
`
`For example,
`
`
`In some of the preferred embodiments of the artificial heart valve of the
`invention, the cuff portion of the valve means extends on only one side of the
`circular portion of the stent member. The flexible valve means preferably
`comprises porcine pericardium configured with three leaflets.
`
`Bessler at col. 4, lines 6-11.
`
`
`According to claim 1 of Bessler, the “cuff portion” is on the outer surface of the stent:
`
`
`An artificial heart valve comprising
`
`a self-expanding, cylindrical stent member having first and second ends and
`an outer surface, and
`
`a valve member comprising one-way valve means arranged within the stent
`and a cuff portion extending on said outer surface to a point between the
`first and second ends,
`
`wherein the cuff portion is configured to position the valve snugly and
`sealingly at a valve site; and
`
`
`EAST\177349076.1
`
`9
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 9 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`wherein the stent member has a plurality of barbs extending from the outer
`surface of the stent member to engage the natural tissue of the heart to hold the
`valve in place after implantation.
`
`Bessler at claim 1 (emphasis added).
`
`
`According to claim 13 of Bessler, the “cuff portion” is on the inner surface of the stent:
`
`
`An artificial heart valve comprising a relatively rigid stent member and a
`flexible valve means disposed in said stent member, said stent member
`comprising a wire formed into a closed zig-zag configuration having an
`endless series of straight sections and a plurality of bends connecting said
`straight sections, said stent member having a first collapsed cylindrical shape
`and being self-expandable to a second expanded cylindrical shape, said stent
`member having a plurality of barbs extending from its outer surface, said valve
`member comprising a circular portion, said circular portion having a
`plurality of leaflets extending from the periphery of said circular portion
`towards the center thereof, said leaflets allowing for flow of blood through
`the valve in one direction only, the diameter of said circular portion being
`substantially the same as the inside diameter of said stent member when
`said stent member is in its expanded cylindrical shape, said valve member
`having a cuff portion extending from the periphery of said circular
`portion, said cuff portion being disposed downstream of said valve
`member and substantially parallel to the cylindrical surface of said stent
`member and said cuff portion being attached to said stent member with a
`plurality of sutures.
`
`Bessler at claim 13 (emphasis added).
`
`
`
`
`EAST\177349076.1
`
`10
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 10 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`1.d
`
`a delivery system including a
`pusher member and a
`moveable sheath, the pusher
`member including a
`guidewire lumen, wherein the
`pusher member is disposed
`within a lumen of the
`moveable sheath, wherein
`
`Bessler discloses “a delivery system including a pusher member and a moveable sheath, the
`pusher member including a guidewire lumen, wherein the pusher member is disposed within
`a lumen of the moveable sheath, wherein”
`
`For example, Bessler discloses a delivery system (device 90) that includes a pusher member
`(pusher member 93 (103 in FIG. 14) + threads 105 (shown in FIG. 14) + loop 107 (shown in
`FIG. 14)) that includes a guidewire lumen (lumen 97) disposed within a lumen of a movable
`sheath (catheter 94):
`
`
`The device set forth in FIGS. 12 and 13 represents a novel device for
`implanting the artificial heart valves of the present invention. The device 90
`comprises a flexible catheter 91 for percutaneous and transluminal delivery of
`the heart valve to the desired site. A heart valve 92 of the invention is carried,
`in its collapsed state, at the distal end of the catheter 91 where the catheter
`walls maintain the valve 92 in its collapsed state. Disposed within the catheter
`91 is a hollow flexible pusher member 93, which is movable longitudinally
`with respect to the catheter 91. A guidewire 94 having a blunt end 95 is
`disposed through a lumen 97 of the pusher member 93 and is used to guide the
`distal end of the catheter 91 to the desired site. Means 96 is also disposed
`through lumen 97 of the pusher member 93 for holding the valve 92 in place
`and allowing release of the valve 92 when desired, as will be more fully
`described in conjunction with FIGS. 14 and 15.
`
`Bessler at col. 6, lines 9-23.
`
`
`
`
`EAST\177349076.1
`
`11
`
`
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 11 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`Bessler at FIG. 12.
`
`
`
`
`Bessler at FIG. 13.
`
`
`
`
`
`
`
`
`1.e
`
`the prosthetic heart valve is
`collapsed onto the pusher
`member to reside in a
`
`
`EAST\177349076.1
`
`Bessler at FIG. 14.
`
`Bessler discloses “the prosthetic heart valve is collapsed onto the pusher member to reside
`in a collapsed configuration on the pusher member and is restrained in the collapsed
`
`
`
`12
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 12 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`collapsed configuration on
`the pusher member and is
`restrained in the collapsed
`configuration by the
`moveable sheath, wherein a
`distal end of the prosthetic
`heart valve is located at a
`distal end of the moveable
`sheath, and wherein
`
`configuration by the moveable sheath, wherein a distal end of the prosthetic heart valve is
`located at a distal end of the moveable sheath, and wherein”
`
`For example:
`
`See claim 1.d above, which is incorporated by reference.
`
`
`The device set forth in FIGS. 12 and 13 represents a novel device for
`implanting the artificial heart valves of the present invention. The device 90
`comprises a flexible catheter 91 for percutaneous and transluminal delivery of
`the heart valve to the desired site. A heart valve 92 of the invention is carried,
`in its collapsed state, at the distal end of the catheter 91 where the catheter
`walls maintain the valve 92 in its collapsed state. Disposed within the catheter
`91 is a hollow flexible pusher member 93, which is movable longitudinally
`with respect to the catheter 91. A guidewire 94 having a blunt end 95 is
`disposed through a lumen 97 of the pusher member 93 and is used to guide the
`distal end of the catheter 91 to the desired site. Means 96 is also disposed
`through lumen 97 of the pusher member 93 for holding the valve 92 in place
`and allowing release of the valve 92 when desired, as will be more fully
`described in conjunction with FIGS. 14 and 15.
`
`Bessler at col. 6, lines 9-23.
`
`
`
`EAST\177349076.1
`
`13
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 13 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`Bessler at FIG. 14 (showing artificial heart valve partially ejected).
`
`
`
`
`
`
`Bessler at FIG. 15 (showing artificial heart valve fully ejected).
`
`
`14
`
`
`EAST\177349076.1
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 14 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`To the extent that the purpose of the “pusher member” is to eject or push out the artificial
`valve 101 from the catheter 102, the “pusher member” includes pair of threads 105 with a
`loop 107 connected to the pusher member 103 because these items, in combination,
`facilitate the ejection of the prosthetic valve 101. As such, the “pusher member” (103, 105
`and 107) passes through the interior of the artificial valve 101. Therefore, artificial valve is
`collapsed onto the pusher member. The artificial valve 101 is also collapsed onto the pusher
`member in the sense that when the artificial valve 101 is collapsed and restrained in the
`collapsed position by the inside wall of catheter 102, the diameter of the artificial valve 101
`is approximately the same diameter of the pusher member 103 and for that reason is
`collapsed onto the distal end of the pusher member 103 as shown in Fig. 14 above.
`
`To the extent that Patent Owner argues that Bessler does not disclose this element, Klint
`additionally teaches this element and it would have been obvious to a POSITA to combine
`Bessler with Teitelbaum and Klint.
`
`For example, Klint broadly teaches a delivery system for implantable devices:
`
`
`In a second embodiment, the medical device may be a delivery system for a
`prosthesis such as a stent, a stent graft, a valve member, or a filter, wherein the
`prosthesis is compressible to be placed within a receptacle at the distal end of
`the delivery catheter and is then radially expandable upon delivery to a
`treatment site after being urged from receptacle.
`
`Klint at paragraph [0021]. Klint’s delivery system includes a shaft portion with a lumen
`extending along its length, wherein a self-expandable prosthesis is arranged in a receptacle
`at the distal end of the delivery device, and a pusher member with engagement means
`extends through the lumen of the delivery device, as shown in the following drawings:
`
`
`
`EAST\177349076.1
`
`15
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 15 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`
`Klint at FIG. 13 (showing the delivery system).
`
`
`
`
`
`Klint at FIG. 16 (showing the distal end of the delivery system and a partially deployed
`prosthesis).
`
`Klint discloses embodiments with two alternative designs for the engagement of the pusher
`member with the prosthesis: (1) delivery systems where the pusher member is adjacent to
`and in contact with the prosthesis; and (2) delivery systems where the pusher member passes
`through the collapsed prosthesis. Klint further explains that the latter arrangement “can be
`an advantage if the prosthesis has an extensive length, and in particular if it has a
`construction having a tendency to buckle when pushed upon.”:
`
`
`16
`
`
`EAST\177349076.1
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 16 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`At the distal end of the pusher member 216 an engagement means 222 can act
`on the prosthesis 220. The engagement means can be for example a plate of a
`dimension fitting into receptacle 208 and abutting the proximal end of the
`prosthesis so that the plate pushes the prosthesis out of the receptacle when the
`pusher member is pushed forwardly. The engagement means can also be
`designed as an elongate member that extends coaxially inside the radially
`compressed prosthesis and engages the prosthesis at several locations along
`the length thereof so that the prostheses is partly pulled, partly pushed out of
`the receptacle. These engagement points or areas can be effected by radial
`projections, hooks, ridges, or another kind of engagement means such as a high
`friction material. This can be an advantage if the prosthesis has an extensive
`length, and in particular if it has a construction having a tendency to buckle
`when pushed upon.
`
`Klint at paragraph [0094].
`
` A
`
` POSITA would have been motivated to modify Bessler and Teitelbaum in light of the
`teachings of Klint, because a POSITA would recognize the advantage of this design, as
`explained by Klint (reducing the risk that the prosthesis will buckle or be damaged during
`delivery from having force applied to it by a pusher member located adjacent to the device).
`A POSITA would also have been motivated to make these combinations because a POSITA
`would recognize that collapsing the prosthesis onto the pusher member permits the
`operator to hold the apparatus steady, such as in the deployment method Teitelbaum
`describes at 5:15-19, 3:54-59, increasing the precision of device placement over pushing a
`device out of a catheter.
`
` A
`
` POSITA would have had a reasonable expectation of success in making these
`combinations, because these combinations represent a simple substitution of one known
`prior art delivery system element (a pusher member adjacent to the collapsed prosthesis)
`with another (a pusher member that extends through the interior of the collapsed prosthesis).
`Indeed, Klint’s use of these two delivery systems as alternatives demonstrates that a
`POSITA would have recognized their interchangeability. And the results of these
`combinations would be predictable as “[c]atheters for medical diagnostic or therapeutic use
`
`
`EAST\177349076.1
`
`17
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 17 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`1.f
`
`the valve means resides
`entirely within the inner
`channel of the stent member
`in said collapsed
`configuration and is
`configured to continue to
`reside entirely within the
`inner channel of the stent
`member upon deployment in
`the patient
`
`[were] [ ] well known”, including catheters that include “a pusher to push a device such as a
`stent from the distal end of the catheter.” Klint at paragraphs [0007]-[0009].
`
`Teitelbaum provides further evidence that a POSITA would have had a reasonable
`expectation of success in making the combination of Bessler, Teitelbaum, and Klint,
`because as discussed above, Teitelbaum teaches teaches the use of a “pusher rod” that is
`“held steady while the sheath is withdrawn.” Teitelbaum at 5:15-19, 3:54-59.
`
`Bessler discloses “the valve means resides entirely within the inner channel of the stent
`member in said collapsed configuration and is configured to continue to reside entirely
`within the inner channel of the stent member upon deployment in the patient”
`
`For example,
`
`See claim 1.c above, which is incorporated by reference. Bessler’s valve resides entirely
`within an inner channel of the stent member:
`
`
`The flexible valve means is disposed within the cylindrical stent member with
`the arcuate portion transverse of and at some acute angle relative to the stent
`walls.
`
`Bessler at col. 3, lines 57-60. The drawings below show the valve means residing entirely
`within the inner channel of the stent member in collapsed configuration and expanded
`configuration:
`
`
`
`EAST\177349076.1
`
`18
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 18 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`Bessler at FIG. 5 (showing stent in a collapsed configuration).
`
`
`
`
`
`
`Bessler at FIG. 4 (showing stent in a fully expanded configuration). The drawing below
`shows the valve means fully ejected in an expanded configuration:
`
`
`
`
`
`EAST\177349076.1
`
`19
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 19 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`2.
`
`The assembly of claim 1,
`wherein the stent member is
`self-expanding
`
`Bessler at FIG. 15 (showing artificial heart valve fully ejected).
`
`Bessler discloses “the stent member is self-expanding.”
`
`For example,
`
`See claim 1 above, which is incorporated by reference.
`
`
`
`
`An artificial heart valve comprises a relatively rigid stent member having a
`first cylindrical shape and a flexible valve disposed in the stent member, the
`stent member being self-expandable to a second cylindrical shape and
`collapsible to its first cylindrical shape.
`
`3.
`
`The assembly of claim 2,
`wherein the stent member
`comprises nitinol
`
`Bessler at Abstract.
`
`Bessler discloses “the stent member comprises nitinol.”
`
`For example,
`
`
`EAST\177349076.1
`
`20
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 20 of 21
`
`

`

`Appendix A-2
`Invalidity of U.S. 9,125,739 in View of Bessler, Klint and Teitelbaum
`
`
`See claim 2 above, which is incorporated by reference.
`
`
`5.
`
`The assembly of claim 1,
`wherein the pusher member
`includes a controlled release
`mechanism that can be
`activated.
`
`The stent members of the artificial heart valves of the present invention may
`be made from Elgiloy alloy, titanium, titanium alloy, nitinol, stainless steel, or
`other
`resilient,
`flexible non-toxic, non-thrombogenic, physiologically
`acceptable and biocompatible materials.
`
`Bessler at col. 6, lines 3-7.
`
`Bessler discloses “the pusher member includes a controlled release mechanism that can be
`activated”
`
`For example,
`
`See claim 1 above, which is incorporated by reference.
`
`
`Once the distal end of the catheter is positioned as desired, the pusher
`mechanism is activated and the distal portion of the artificial heart valve is
`pushed out of the catheter and the stent member partially expands. In this
`position the stent member is restrained so that it doesn't pop out and is held for
`controlled release, with the potential that the artificial heart valve can be
`recovered if there is a problem with the positioning or the like. The catheter is
`them retracted slightly and the artificial heart valve is completely pushed out
`of the catheter and released from the catheter to allow the stent member to fully
`expand.
`
`
`
`
`
`
`EAST\177349076.1
`
`Bessler at col. 4, line 63- col. 5, line 6.
`
`
`
`21
`
`Colibri Heart Valve LLC, Exhibit 2012, Page 21 of 21
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket